Calcitonin Inhibits SDCP-Induced Osteoclast Apoptosis and Increases Its Efficacy in a Rat Model of Osteoporosis

Molecular Mechanisms in Coupling of Bone Formation to Resorption

(2012) T. John Martin et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Biochemical and molecular mechanisms of action of bisphosphonates

(2010) Michael J. Rogers et al.   BONE

Back to the Future: Revisiting Parathyroid Hormone and Calcitonin Control of Bone Remodeling

(2010) F. J. A. de Paula et al.   HORMONE AND METABOLIC RESEARCH

Guidelines for assessment of bone microstructure in rodents using micro-computed tomography

(2010) Mary L Bouxsein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Molecular biology of bone remodeling: Implications for new therapeutic targets for osteoporosis

(2010) J. Chris Gallagher et al.   MATURITAS

Effects of short-term combined treatment with alendronate and elcatonin on bone mineral density and bone turnover in postmenopausal women with osteoporosis

(2010) Jun Jun Iwamoto   Therapeutics and Clinical Risk Management

Bisphosphonates: Mechanism of Action and Role in Clinical Practice

(2009) Matthew T. Drake et al.   MAYO CLINIC PROCEEDINGS

RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro

(2009) Karen A Sutherland et al.   ARTHRITIS RESEARCH & THERAPY

The role of calcitonin and α-calcitonin gene-related peptide in bone formation

(2008) Antje K. Huebner et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis

(2008) Letizia Penolazzi et al.   BMC Complementary and Alternative Medicine

Calcitonin Receptor Plays a Physiological Role to Protect Against Hypercalcemia in Mice

(2008) Rachel A Davey et al.   JOURNAL OF BONE AND MINERAL RESEARCH